Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.

Accepted 2023-10-12 00:00:00 ET · period of report 2023-10-10 · accession 0001127602-23-025798 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-10-12	2023-10-10+	LXRX	DEBBANE RAYMOND	Dir	P - Purchase	$1.10	+1.00M	1.19M	+521%	+$1.10M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-10-12	P	A	148,820	$1.03	1,340,847	D	—	—	(F3) This transaction was executed in multiple trades at prices ranging from $1.02 to $1.07 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.
2	Common	Common Stock	2023-10-10	P	A	508,306	$1.14	849,153	D	—	—	(F1) This transaction was executed in multiple trades at prices ranging from $1.09 to $1.19 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.
3	Common	Common Stock	2023-10-11	P	A	342,874	$1.08	1,192,027	D	—	—	(F2) This transaction was executed in multiple trades at prices ranging from $1.06 to $1.12 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.